These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23592399

  • 1. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
    Mukhopadhyay A, Khoury T, Stein L, Shrikant P, Sood AK.
    Oncotarget; 2013 Apr; 4(4):610-21. PubMed ID: 23592399
    [Abstract] [Full Text] [Related]

  • 2. PDEF and PDEF-induced proteins as candidate tumor antigens for T cell and antibody-mediated immunotherapy of breast cancer.
    Sood AK.
    Immunol Res; 2010 Mar; 46(1-3):206-15. PubMed ID: 19763888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
    Ghadersohi A, Pan D, Fayazi Z, Hicks DG, Winston JS, Li F.
    Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
    [Abstract] [Full Text] [Related]

  • 5. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
    Turcotte S, Forget MA, Beauseigle D, Nassif E, Lapointe R.
    Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
    [Abstract] [Full Text] [Related]

  • 6. Novel role for PDEF in epithelial cell migration and invasion.
    Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS.
    Cancer Res; 2005 Dec 15; 65(24):11572-80. PubMed ID: 16357167
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells.
    Lewis-Wambi JS, Cunliffe HE, Kim HR, Willis AL, Jordan VC.
    Eur J Cancer; 2008 Aug 15; 44(12):1770-9. PubMed ID: 18614350
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.
    Iwabuchi E, Miki Y, Onodera Y, Shibahara Y, Takagi K, Suzuki T, Ishida T, Sasano H.
    Clin Exp Metastasis; 2019 Oct 15; 36(5):423-432. PubMed ID: 31222613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
    Sood AK, Geradts J, Young J.
    Tumour Biol; 2017 May 15; 39(5):1010428317691688. PubMed ID: 28468594
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
    Sabherwal Y, Mahajan N, Zhang M.
    Oncol Rep; 2013 Oct 15; 30(4):1985-8. PubMed ID: 23921628
    [Abstract] [Full Text] [Related]

  • 16. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
    Tsang JY, Kwok YK, Chan KW, Ni YB, Chow WN, Lau KF, Shao MM, Chan SK, Tan PH, Tse GM.
    Breast Cancer Res Treat; 2013 Nov 15; 142(2):311-22. PubMed ID: 24186057
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Steffan JJ, Koul HK.
    Cancer Lett; 2011 Nov 01; 310(1):109-17. PubMed ID: 21764212
    [Abstract] [Full Text] [Related]

  • 19. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
    Blumenthal RD, Leon E, Hansen HJ, Goldenberg DM.
    BMC Cancer; 2007 Jan 03; 7():2. PubMed ID: 17201906
    [Abstract] [Full Text] [Related]

  • 20. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
    Ghadersohi A, Odunsi K, Zhang S, Azrak RG, Bundy BN, Manjili MH, Li F.
    Int J Cancer; 2008 Sep 15; 123(6):1376-84. PubMed ID: 18567002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.